{'fraction_non_alphanumeric': 0.03331238214959145, 'fraction_numerical': 0.03016970458830924, 'mean_word_length': 5.578512396694215, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Control of pyrethroid‐resistant populations of Triatoma infestans, the main vector of Trypanosoma cruzi, by treating dogs with fluralaner in the Argentine Chaco

We assessed whether fluralaner administered to outbred healthy dogs reduced or supressed site infestation and abundance of pyrethroid‐resistant populations of Triatoma infestans Klug (Heteroptera: Reduviidae). We conducted a placebo‐controlled before‐and‐after efficacy trial in 28 infested sites in Castelli (Argentine Chaco) over 10 months. All 72 dogs initially present received either an oral dose of fluralaner (treated group) or placebo (control group) at month 0 posttreatment (MPT). Preliminary results justified treating all 38 control‐house dogs with fluralaner 1 month later, and 71 of 78 existing dogs at 7 MPT. Site‐level infestation and triatomine abundance were evaluated using timed manual searches with a dislodging aerosol. In the fluralaner‐treated group, infestation dropped significantly from 100% at baseline to 19% over 6–10 MPT whereas mean abundance fell highly significantly from 5.5 to 0.8–0.9 triatomines per unit effort. In the placebo group, site infestation and mean abundance remained stable between 0 and 1 MPT, and strongly declined after fluralaner administration from 13.0−14.7 ‐ triatomines at 0–1 MPT to 4.0–4.2 over 6–10 MPT. Only one of 81 noninfested sites before fluralaner treatment became infested subsequently. Fluralaner significantly reduced the site‐level infestation and abundance of pyrethroid‐resistant T. infestans and should be tested more widely in Phase III efficacy trials.